The Zeus CathX Medical business has leased this faciilty Cartago, Costa Rica. [Photo courtesy of Zeus]
“This investment reflects how we think about supporting our customers over the long term,” Zeus CEO Paddy O’Brien said in a news release announcing the move. “As their programs move from development to commercial scale, they need a partner with the capacity and consistency to grow alongside them. Costa Rica strengthens our ability to do that, extending the same quality system and manufacturing discipline our customers rely on today into the volumes they will need tomorrow.”
The site will initially focus on catheter sub-assembly operations as demand grows for minimally invasive devices and procedures that utilize complex catheters.
The facility is now in its build-out and hiring phase, with operational readiness expected in the second quarter 2027 following equipment installation, validation and workforce onboarding, the company said.
MDO Min-Vasive Medtech: Join us Aug. 18-20 to learn minimally invasive medtech tips and tricks from experts in robotics, imaging and cardiac devices
The CathX Medical business expects to hire 100 team members in Costa Rica over the next 12 to 18 months, including positions in engineering, technical and manufacturing operations, the company said.
Zeus said the lease includes long-term renewal rights and the option to expand within the park as the business grows.
The Costa Rica facility “complements CathX Medical’s sites in San Jose, California, and Arden Hills, Minnesota, and advances the company’s three-site model. New products are developed and built in low volumes in the U.S., and Costa Rica supports commercial-scale manufacturing as those programs mature, all under the same quality management system, equipment and tooling,” the company said.
“Everyone in this business knows where programs stall, and it’s almost never the science, it’s the handoff from development into full-scale production,” CathX Medical Catheter Solutions VP Matt Bradbury said in the news release. “That’s the gap we designed the CathX model to close, and Costa Rica is the piece that completes it, giving a program one continuous path from prototype to commercial volume under a single team and quality system. For our customers, that can be the difference between a device that makes it to market and one that stalls on the way.”
Said Zeus Chief Commercial Officer Jim O’Connell, “Our customers are looking for manufacturing partners they can count on as their programs scale globally. This investment gives them added capacity and greater supply chain resilience, along with the confidence that Zeus can support their programs wherever they are headed.”
